Shenkman Capital Management »

Bridgebio Pharma shares owned by Shenkman Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Shenkman Capital Management from 13F filings

Historical chart of Shenkman Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Shenkman Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Shenkman Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.2B 1.1M 1077.48
2023-12-31 $913M 750k 1217.86

More positions owned by Shenkman Capital Management

Digitalocean Hldgs Note 12/0 (Principal)
Spdr Ser Tr Bloomberg Sht Te (SJNK)
Enphase Energy Note 3/0 (Principal)
Uber Technologies Note 12/1 (Principal)
Ford Mtr Co Del Note 3/1 (Principal)
Blackline Note 0.125% 8/0 (Principal)
Diamond Offshore Drilli (DO)
Akamai Technologies Note 0.375% 9/0 (Principal)
Dexcom Note 0.250%11/1 (Principal)
Ziff Davis Note 1.750%11/0 (Principal)
Snap Note 0.750% 8/0 (Principal)
On Semiconductor Corp Note 0.500% 3/0 (Principal)
Envestnet Note 2.625%12/0 (Principal)
Exact Sciences Corp Note 0.375% 3/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)

View all positions for Shenkman Capital Management

Top funds holding Bridgebio Pharma

Braidwell
Graham Capital Management
Wolverine Asset Management
Aristeia Capital
Weiss Asset Management LP[1
D. E. Shaw & Co
683 Capital Management
Lazard Asset Management
Wells Fargo & Company
Point72 Asset Management
Calamos Advisors
Ubs Global Asset Management Americas
Lord, Abbett & Co
SSI Investment Management
BlackRock

View all funds holding Bridgebio Pharma